EP Patent

EP0487774A1 — A direct tabletting auxiliary

Assigned to Wei Ming Pharmaceutical Mfg Co Ltd · Expires 1992-06-03 · 34y expired

What this patent protects

A direct tabletting auxiliary contains, in an intimate mixture, the essential components A) from 60 to 98% by weight, based on the direct tabletting auxiliary, of microcrystalline cellulose, cornstarch, mannitol, lactose, sorbitol, cellulose powder, calcium sulfate, calciuöm…

USPTO Abstract

A direct tabletting auxiliary contains, in an intimate mixture, the essential components A) from 60 to 98% by weight, based on the direct tabletting auxiliary, of microcrystalline cellulose, cornstarch, mannitol, lactose, sorbitol, cellulose powder, calcium sulfate, calciuöm phosphate, calcium carbonate, sodium starch glycolate or calcium carboxymethyl cellulose, B) from 2 to 40% by weight, based on the direct tabletting auxiliary, of a binder selected from the group comprising hydroxypropylmethylcellulose, hydroxypropylcellulose, hydroxyethylcellulose, methylcellulose, pregelatinized starch maltodextrin, polyvinylpyrrolidone, gelatin and α-, β- or γ-cyclodextrin, where the intimate mixture of A and B has been produced in the presence of water using a wet mixing process and simultaneous or subsequent drying.

Drugs covered by this patent

Patent Metadata

Patent number
EP0487774A1
Jurisdiction
EP
Classification
Expires
1992-06-03
Drug substance claim
No
Drug product claim
No
Assignee
Wei Ming Pharmaceutical Mfg Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.